ArticleJAMA neurology2019

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis.

Katharine Harding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.